Promising Alzheimer’s drug candidate prevents buildup of tau proteins in lab and fruit fly studies

An international team of researchers led by Lancaster University has made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting “hotspots” of the tau protein in the brain—a key driver of neurodegeneration.